Trade BIO-key International, Inc. - BKYI CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0133 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 0.5033 |
Open* | 0.4759 |
1-Year Change* | -67.4% |
Day's Range* | 0.4759 - 0.4984 |
52 wk Range | 0.46-1.74 |
Average Volume (10 days) | 14.47K |
Average Volume (3 months) | 491.71K |
Market Cap | 5.09M |
P/E Ratio | -100.00K |
Shares Outstanding | 9.26M |
Revenue | 8.14M |
EPS | -1.31 |
Dividend (Yield %) | N/A |
Beta | 1.04 |
Next Earnings Date | Nov 13, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 29, 2023 | 0.5033 | -0.0151 | -2.91% | 0.5184 | 0.5284 | 0.4634 |
Sep 28, 2023 | 0.4984 | -0.0013 | -0.26% | 0.4997 | 0.5199 | 0.4734 |
Sep 27, 2023 | 0.5445 | 0.0495 | 10.00% | 0.4950 | 0.5445 | 0.4924 |
Sep 26, 2023 | 0.4884 | 0.0150 | 3.17% | 0.4734 | 0.5044 | 0.4734 |
Sep 25, 2023 | 0.4925 | 0.0000 | 0.00% | 0.4925 | 0.5275 | 0.4734 |
Sep 22, 2023 | 0.4734 | -0.0384 | -7.50% | 0.5118 | 0.5118 | 0.4568 |
Sep 21, 2023 | 0.4869 | -0.0368 | -7.03% | 0.5237 | 0.5295 | 0.4761 |
Sep 20, 2023 | 0.4834 | 0.0048 | 1.00% | 0.4786 | 0.5035 | 0.4786 |
Sep 19, 2023 | 0.4869 | -0.0115 | -2.31% | 0.4984 | 0.5046 | 0.4734 |
Sep 18, 2023 | 0.4984 | -0.0100 | -1.97% | 0.5084 | 0.5525 | 0.4833 |
Sep 15, 2023 | 0.5184 | -0.0100 | -1.89% | 0.5284 | 0.5583 | 0.5019 |
Sep 14, 2023 | 0.5034 | -0.0043 | -0.85% | 0.5077 | 0.5327 | 0.4984 |
Sep 13, 2023 | 0.5113 | -0.0221 | -4.14% | 0.5334 | 0.5582 | 0.5077 |
Sep 12, 2023 | 0.5084 | 0.0007 | 0.14% | 0.5077 | 0.5284 | 0.5077 |
Sep 11, 2023 | 0.5084 | 0.0007 | 0.14% | 0.5077 | 0.5304 | 0.5077 |
Sep 5, 2023 | 0.4974 | -0.0121 | -2.37% | 0.5095 | 0.5374 | 0.4974 |
Sep 1, 2023 | 0.5295 | 0.0200 | 3.93% | 0.5095 | 0.5295 | 0.5095 |
Aug 31, 2023 | 0.5702 | 0.0007 | 0.12% | 0.5695 | 0.5702 | 0.5695 |
Aug 24, 2023 | 0.5395 | -0.0317 | -5.55% | 0.5712 | 0.5712 | 0.5395 |
Aug 23, 2023 | 0.5711 | -0.0184 | -3.12% | 0.5895 | 0.5983 | 0.5695 |
BIO-key International, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, November 13, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q3 2023 BIO-Key International Inc Earnings Release Q3 2023 BIO-Key International Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 7.02026 | 5.11449 | 2.83678 | 2.26753 | 4.04454 |
Revenue | 7.02026 | 5.11449 | 2.83678 | 2.26753 | 4.04454 |
Cost of Revenue, Total | 2.43957 | 1.67293 | 0.79483 | 2.46125 | 4.16419 |
Gross Profit | 4.58069 | 3.44156 | 2.04195 | -0.19372 | -0.11965 |
Total Operating Expense | 17.4439 | 10.0563 | 8.53903 | 15.7872 | 10.9135 |
Selling/General/Admin. Expenses, Total | 9.36489 | 6.02836 | 5.84869 | 5.03682 | 5.33391 |
Research & Development | 3.25224 | 2.35506 | 1.39644 | 1.33167 | 1.4154 |
Operating Income | -10.4236 | -4.94186 | -5.70225 | -13.5197 | -6.86896 |
Interest Income (Expense), Net Non-Operating | -0.85925 | -0.12393 | -4.31256 | -1.06898 | 0.00008 |
Net Income Before Taxes | -11.9303 | -5.06578 | -9.67399 | -14.5887 | -6.86888 |
Net Income After Taxes | -11.9099 | -5.06578 | -9.67399 | -14.5887 | -6.86888 |
Net Income Before Extra. Items | -11.9099 | -5.06578 | -9.67399 | -14.5887 | -6.86888 |
Net Income | -11.9099 | -5.06578 | -9.67399 | -14.5887 | -6.86888 |
Total Adjustments to Net Income | 0 | -0.11269 | 0 | -1.627 | |
Income Available to Common Excl. Extra. Items | -11.9099 | -5.06578 | -9.78667 | -14.5887 | -8.49587 |
Income Available to Common Incl. Extra. Items | -11.9099 | -5.06578 | -9.78667 | -14.5887 | -8.49587 |
Diluted Net Income | -11.9099 | -5.06578 | -9.78667 | -14.5887 | -8.49587 |
Diluted Weighted Average Shares | 8.10079 | 7.79174 | 4.70079 | 1.77796 | 1.45099 |
Diluted EPS Excluding Extraordinary Items | -1.47022 | -0.65015 | -2.08192 | -8.2053 | -5.85522 |
Diluted Normalized EPS | -1.27867 | -0.65015 | -1.97575 | -4.2921 | -5.85522 |
Unusual Expense (Income) | 2.38719 | 0 | 0.49908 | 6.95752 | |
Other, Net | -0.64746 | 0 | 0.34082 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1.92893 | 3.08377 | 1.75842 | 1.37355 | 1.94712 |
Revenue | 1.92893 | 3.08377 | 1.75842 | 1.37355 | 1.94712 |
Cost of Revenue, Total | 0.60611 | 0.82027 | 0.98439 | 0.39378 | 0.72395 |
Gross Profit | 1.32282 | 2.2635 | 0.77403 | 0.97977 | 1.22317 |
Total Operating Expense | 3.10746 | 3.44217 | 7.25458 | 3.734 | 3.51461 |
Selling/General/Admin. Expenses, Total | 1.94316 | 1.93173 | 3.04961 | 2.51071 | 2.00657 |
Research & Development | 0.55818 | 0.69016 | 0.83338 | 0.82951 | 0.78408 |
Unusual Expense (Income) | 2.38719 | ||||
Operating Income | -1.17853 | -0.3584 | -5.49616 | -2.36045 | -1.56749 |
Interest Income (Expense), Net Non-Operating | -0.10136 | 0.07008 | -0.66586 | -0.04206 | -0.15146 |
Net Income Before Taxes | -1.27988 | -0.28832 | -6.80947 | -2.40251 | -1.71896 |
Net Income After Taxes | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Net Income Before Extra. Items | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Net Income | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Total Adjustments to Net Income | |||||
Income Available to Common Excl. Extra. Items | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Income Available to Common Incl. Extra. Items | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Diluted Net Income | -1.42288 | -0.28832 | -6.78903 | -2.40251 | -1.71896 |
Diluted Weighted Average Shares | 9.02143 | 8.94449 | 8.24052 | 8.14885 | 8.09802 |
Diluted EPS Excluding Extraordinary Items | -0.15772 | -0.03223 | -0.82386 | -0.29483 | -0.21227 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.15772 | -0.03223 | -0.63556 | -0.29483 | -0.21227 |
Other, Net | -0.64746 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 8.98488 | 14.0129 | 18.9419 | 1.36629 | 4.2293 |
Cash and Short Term Investments | 2.63552 | 7.75405 | 17.5059 | 0.59183 | 0.32394 |
Cash & Equivalents | 2.63552 | 7.75405 | 16.9931 | 0.07901 | 0.32394 |
Total Receivables, Net | 1.57228 | 1.10213 | 0.9035 | 0.23694 | 1.63071 |
Accounts Receivable - Trade, Net | 1.52278 | 0.97063 | 0.54805 | 0.126 | 1.57403 |
Total Inventory | 4.43437 | 4.94066 | 0.33095 | 0.42912 | 0.99883 |
Prepaid Expenses | 0.34271 | 0.21604 | 0.20151 | 0.1084 | 0.15081 |
Other Current Assets, Total | 0 | 1.125 | |||
Total Assets | 11.3443 | 17.769 | 22.5206 | 2.4967 | 11.6923 |
Property/Plant/Equipment, Total - Net | 0.30477 | 0.32327 | 0.56912 | 0.66199 | 0.14861 |
Intangibles, Net | 1.76283 | 1.34683 | 1.57303 | 0.22819 | 6.98652 |
Note Receivable - Long Term | 0.113 | 0 | |||
Other Long Term Assets, Total | 0.29178 | 0.25772 | 0.17403 | 0.24023 | 0.32791 |
Total Current Liabilities | 4.43666 | 1.99931 | 1.8763 | 4.39141 | 1.22611 |
Accounts Payable | 1.10828 | 0.42777 | 0.24416 | 0.91929 | 0.48127 |
Accrued Expenses | 1.16879 | 1.00619 | 0.7428 | 0.85745 | 0.54823 |
Notes Payable/Short Term Debt | 1.57717 | 0 | 0.232 | 2.25545 | 0 |
Other Current Liabilities, Total | 0.46242 | 0.56536 | 0.65735 | 0.35921 | 0.19661 |
Total Liabilities | 4.85339 | 2.15359 | 2.18545 | 4.78187 | 1.22611 |
Total Long Term Debt | 0.32677 | 0 | 0 | 0 | 0 |
Total Equity | 6.49087 | 15.6155 | 20.3351 | -2.28517 | 10.4662 |
Redeemable Preferred Stock | 0 | ||||
Preferred Stock - Non Redeemable, Net | 0 | ||||
Common Stock | 0.00092 | 0.00079 | 0.00078 | 0.00144 | 0.0014 |
Additional Paid-In Capital | 122.029 | 120.19 | 119.844 | 87.4364 | 85.5991 |
Retained Earnings (Accumulated Deficit) | -115.296 | -104.575 | -99.5097 | -89.723 | -75.1343 |
Total Liabilities & Shareholders’ Equity | 11.3443 | 17.769 | 22.5206 | 2.4967 | 11.6923 |
Total Common Shares Outstanding | 9.1905 | 7.85376 | 7.81457 | 1.80143 | 1.74723 |
Total Preferred Shares Outstanding | 0 | ||||
Short Term Investments | 0 | 0.51282 | 0.51282 | ||
Property/Plant/Equipment, Total - Gross | 1.30714 | 1.49834 | 1.43429 | ||
Accumulated Depreciation, Total | -0.98388 | -0.92923 | -0.7723 | ||
Other Liabilities, Total | 0.08996 | 0.15427 | 0.30915 | 0.39047 | |
Goodwill, Net | 1.26253 | 1.26253 | |||
Long Term Investments | 0.45282 | ||||
Current Port. of LT Debt/Capital Leases | 0.12 | ||||
Long Term Debt | 0.32677 | ||||
Other Equity, Total | -0.2426 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 8.89383 | 8.98488 | 9.88255 | 12.349 | 13.8061 |
Cash and Short Term Investments | 0.66765 | 2.63552 | 2.77462 | 4.89304 | 5.80112 |
Cash & Equivalents | 0.66765 | 2.63552 | 2.77462 | 4.89304 | 5.80112 |
Short Term Investments | |||||
Total Receivables, Net | 3.51489 | 1.57228 | 1.85754 | 2.23565 | 2.68718 |
Accounts Receivable - Trade, Net | 3.45714 | 1.52278 | 1.80804 | 2.03906 | 2.55333 |
Total Inventory | 4.42782 | 4.43437 | 4.89267 | 4.8886 | 4.95647 |
Prepaid Expenses | 0.28348 | 0.34271 | 0.35773 | 0.3317 | 0.36137 |
Total Assets | 11.0638 | 11.3443 | 15.026 | 17.6249 | 19.403 |
Property/Plant/Equipment, Total - Net | 0.22539 | 0.30477 | 0.3892 | 0.34203 | 0.33167 |
Goodwill, Net | 2.1977 | 2.2564 | 1.7208 | ||
Intangibles, Net | 1.68159 | 1.76283 | 1.84036 | 1.99637 | 2.69305 |
Note Receivable - Long Term | 0.146 | 0.06836 | 0.11 | ||
Other Long Term Assets, Total | 0.26299 | 0.29178 | 0.30739 | 0.30994 | 0.2885 |
Total Current Liabilities | 4.67354 | 4.43666 | 3.34357 | 3.53255 | 3.48828 |
Accounts Payable | 1.19122 | 1.10828 | 1.06857 | 1.2793 | 1.01427 |
Accrued Expenses | 0.97287 | 1.16879 | 1.05418 | 1.0423 | 1.05218 |
Notes Payable/Short Term Debt | 1.72333 | 1.57717 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.65334 | 0.46242 | 1.10082 | 1.08895 | 1.29883 |
Total Liabilities | 5.02803 | 4.85339 | 3.8275 | 4.00537 | 4.02143 |
Total Long Term Debt | 0.28115 | 0.32677 | 0.32187 | 0.37929 | 0.42374 |
Other Liabilities, Total | 0.07334 | 0.08996 | 0.16206 | 0.09353 | 0.10941 |
Total Equity | 6.03577 | 6.49087 | 11.1985 | 13.6195 | 15.3816 |
Common Stock | 0.00092 | 0.00092 | 0.00085 | 0.00084 | 0.00084 |
Additional Paid-In Capital | 122.1 | 122.029 | 121.123 | 121.023 | 120.9 |
Retained Earnings (Accumulated Deficit) | -115.823 | -115.296 | -109.696 | -107.294 | -105.575 |
Total Liabilities & Shareholders’ Equity | 11.0638 | 11.3443 | 15.026 | 17.6249 | 19.403 |
Total Common Shares Outstanding | 9.22606 | 9.1905 | 8.45262 | 8.44157 | 8.40645 |
Long Term Investments | 0.26282 | 0.30282 | 0.45282 | ||
Current Port. of LT Debt/Capital Leases | 0.13278 | 0.12 | 0.12 | 0.122 | 0.123 |
Long Term Debt | 0.28115 | 0.32677 | 0.32187 | 0.37929 | 0.42374 |
Other Equity, Total | -0.2426 | -0.2426 | -0.22935 | -0.11008 | 0.0558 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -11.9099 | -5.06578 | -9.67399 | -14.5887 | -6.86888 |
Cash From Operating Activities | -6.22903 | -8.97843 | -4.95011 | -1.85035 | -1.61348 |
Cash From Operating Activities | 0.04379 | 0.05465 | 0.08575 | 0.08185 | 0.08462 |
Amortization | 0.34687 | 0.2262 | 0.12024 | 0.88654 | 1.52883 |
Non-Cash Items | 5.60967 | 1.08662 | 5.89771 | 9.64105 | 2.96836 |
Cash Interest Paid | 0.01046 | 0.018 | 0.10943 | 0.07282 | 0 |
Changes in Working Capital | -0.29902 | -5.28012 | -1.37982 | 2.12891 | 0.67359 |
Cash From Investing Activities | -0.69662 | -0.04202 | -2.22982 | -0.54331 | -0.08246 |
Capital Expenditures | -0.08204 | -0.04202 | -0.03557 | -0.02875 | -0.05206 |
Cash From Financing Activities | 1.90324 | -0.2186 | 24.094 | 2.14873 | 1.73116 |
Financing Cash Flow Items | -0.00523 | -2.69302 | -0.36127 | -0.14395 | |
Total Cash Dividends Paid | |||||
Issuance (Retirement) of Stock, Net | 0.05638 | 0.03663 | 27.777 | 0 | 1.8751 |
Issuance (Retirement) of Debt, Net | 1.84686 | -0.25 | -0.98999 | 2.51 | |
Net Change in Cash | -5.11852 | -9.23905 | 16.9141 | -0.24493 | 0.03522 |
Other Investing Cash Flow Items, Total | -0.61458 | 0 | -2.19425 | -0.51456 | -0.0304 |
Cash Taxes Paid | 0.02568 | 0 | 0 | 0 | 0 |
Deferred Taxes | -0.02043 | ||||
Foreign Exchange Effects | -0.09611 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -11.9099 | -5.12087 | -2.71836 | -0.9994 | |
Cash From Operating Activities | -6.22903 | -4.3284 | -2.28745 | -1.43438 | |
Cash From Operating Activities | 0.04379 | 0.03381 | 0.02178 | 0.01122 | |
Amortization | 0.34687 | 0.21681 | 0.1064 | 0.05423 | |
Non-Cash Items | 5.60967 | 0.82218 | 0.47376 | 0.22205 | |
Cash Interest Paid | 0.01046 | 0.00366 | 0.00154 | 0 | |
Changes in Working Capital | -0.29902 | -0.28033 | -0.17103 | -0.72248 | |
Cash From Investing Activities | -0.69662 | -0.52652 | -0.52034 | -0.54504 | |
Capital Expenditures | -0.08204 | -0.03107 | -0.02289 | -0.00446 | |
Cash From Financing Activities | 1.90324 | 0 | 0 | 0 | |
Financing Cash Flow Items | 0 | 0 | 0 | ||
Issuance (Retirement) of Stock, Net | 0.05638 | ||||
Issuance (Retirement) of Debt, Net | 1.84686 | 0 | 0 | 0 | |
Net Change in Cash | -5.11852 | -4.97943 | -2.861 | -1.95293 | |
Other Investing Cash Flow Items, Total | -0.61458 | -0.49545 | -0.49745 | -0.54058 | |
Cash Taxes Paid | 0.02568 | ||||
Foreign Exchange Effects | -0.09611 | -0.12451 | -0.05322 | 0.02649 | |
Deferred Taxes | -0.02043 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BIO-key International, Inc. Company profile
About BIO-key International, Inc.
BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company's products include PortalGuard and PortalGuard identity-as-a-service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to customers. PortalGuard IDaaS offers flexible single sign-on and authentication options to meet users' security goals and deliver an optimized user experience. WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration application programming interfaces (APIs), allowing software developers to leverage its platform to securely embed biometric multi-factor authentication (MFA), into their own products.
Financial summary
BRIEF: For the nine months ended 30 September 2021, BIO-key International, Inc. revenues increased from $1.8M to $4.2M. Net loss applicable to common stockholders decreased 64% to $3M. Revenues reflect License fees increase from $605K to $2M, Hardware increase from $239K to $1.2M, Services increase of 6% to $985K. Lower net loss reflects Interest expense decrease of 100% to $18K (expense), Loss on extinguishment of debt decrease from $499K (expense) to
Equity composition
Common Stock $.0001 Par, 03/11, 170M auth., 78,155,413 issd. Insiders control 0.49%. IPO: 2/97,2,420,000 shares @ $3 by Tuschner & Company, Inc. 7/97, 2-for-1 stock split. Series A Convertible Preferred Stock $.0001 Par, 100K auth., 30,557 issd. Series D Convertible Preferred Stock $.0001 Par, 02/15, 1-for-2 reverse stock split.
Industry: | Biometric Products |
101 Crawfords Corner Rd
Suite 4116
HOLMDEL
NEW JERSEY 07733
US
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com